Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

VTGN US Equity

Vistagen Therapeutics, Inc.Health Care · Pharmaceutical Preparations · CIK 1411685 · FY ends Mar 31
$0.24
+0.00 (+0.87%)
USD · as of 2026-08-19 · marketstack
4 8-K filings · 0 13D · 3 13G
DateEventWhat happened / filerSource
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by ORBIMED ADVISORS LLCsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by TCG Crossover GP I, LLCsec.gov ↗
2026-08-1413G/ASchedule 13G amendment — ≥5% beneficial owner (passive) · by Commodore Capital LPsec.gov ↗
2026-08-148-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-068-K 8.01Other eventssec.gov ↗
2026-08-068-K 7.01Regulation FD disclosuresec.gov ↗
2026-08-058-K 3.01Notice of delisting or failure to satisfy a listing rulesec.gov ↗
2026-07-318-K 7.01Regulation FD disclosuresec.gov ↗
2026-07-318-K 5.02Departure/election of directors or officers; compensationsec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-31

Every row is a filed document, checked against its EDGAR index.